Category Archives: BioEngineering

The Indian Institute of Technology - Hyderabad (IIT-H) researchers have unravelled the working of a protein that repairs damaged DNA.

Nature has evolved techniques to not only protect DNA, but also repair damaged DNA so that a catastrophic damage can be averted.

In humans, one such repair mechanism involves activation of a special class of proteins called DNA repair proteins.

With increasing awareness of the impact of DNA damage on almost all diseases and maladies, there is a worldwide effort to understand how these repair proteins work, both as an academic exercise and as the foundation for therapeutic interventions.

The research team was headed by associate professor, department of biotechnology, Anindya Roy. The research was funded by Science and Engineering Research Board, department of science and technology, Government of India.

The results of the study, conducted in collaboration with professor of the department of biosciences and bioengineering of IIT- Guwahati, Arun Goyal, has been published recently in the journal Nucleic Acid Research. The paper has been co-authored by Dr. Anindya Roy, Dr. Arun Goyal and research scholars namely Monisha Mohan, Deepa Akula and Arun Dhillon.

What makes matter a living being, be it a bacterium or man, is a DNA. DNA is the blueprint of life form and encodes directions that the life form must take in order to become a bacterium, rose, lion or man.

It is thus essential for the survival of every cell and is usually kept well-protected within the nucleus of cells, and in some non-nuclear parts like the mitochondria.

Any damage to DNA can result in outcomes that can range from mild changes that cannot be perceived like a sudden appearance of a harmless mole to catastrophic diseases like cancer. The retention of DNA integrity is therefore essential for proper function and survival of all organisms.

Protection of DNA is daunting because of the possibility of damage by external sources and the intrinsic instability of DNA itself.

Our laboratory at IIT-Hyderabad seeks to understand the working of DNA damage repair proteins. Certain types of chemicals produced naturally in the body can cause damages in DNA and, if not fixed fast, may trigger cell death, Dr. Anindya Roy said.

Ms. Monisha Mohan discovered the mechanism by which these DNA repair proteins assemble when DNA is under threat. They studied the action of one specific protein called alkB homolog 3, or ALKBH3. It is known that ALKBH3 repairs alkylated DNA containing 1-methyladenosine and 3-methylcytosine through oxidative demethylation, but the mechanism has hitherto remained unclear.

Dr. Anindya Roy and the research team have unravelled the mechanism by which ALKBH3 brings about demethylation.

We have found that ALKBH3 has a direct protein-protein interaction with another protein called RAD51C and this interaction stimulates ALKBH3-mediated repair of methyl-adduct located within 3- tailed DNA, adds Dr. Anindya Roy on the technical aspects of their discovery.

The team is fascinated by the universality of the mechanism it is just as applicable to the bacterium as it is to human beings.

The knowledge gained from our studies might, in the long term, be beneficial from a cancer therapeutic perspective, hopes Dr. Anindya Roy, as his team proceeds with work on understanding how DNA repair works.

You have reached your limit for free articles this month.

Register to The Hindu for free and get unlimited access for 30 days.

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Follow this link:
Decoding protein that repairs damaged DNA - The Hindu

PALO ALTO, Calif. (Ivanhoe Newswire) The tiniest of tiny, preemies, weighing in at three, two, even one pound are being born, surviving and thriving. The youngest baby to survive was born at just 21 weeks.

Baby James is now in his mid-20s and perfectly healthy. Any baby born before 37 weeks is considered premature. Right now, theres no telling which moms will deliver early and which ones will go the full 40 weeks. But soon a simple blood test may be able to pinpoint a due date and save little lives.

You could say Haven and his mom are both heroes.

Havens mother Amanda Smith said, I tell people this is like a war zone, only this time its not my life on the line, its my little innocent childs. Smith, an Iraq and Afghanistan war vet and NATO medal of honor recipient, gave birth to Haven 100 days early, weighing just nine-tenths of a pound.

Its about the size of coke can, Smith said.

Haven is one of 450,000 babies in the U.S. born prematurely each year. For two-thirds of those deliveries, no one knows why. Mira Moufarrej, a Bioengineering PhD Student at Stanford University said, When people think about what tools an obstetrician has right now to look at a pregnancy, its ultrasound and thats it.

Now bioengineers at Stanford have developed a blood test that detects with 80 percent accuracy who will deliver early. Something that ultrasound cannot do.

Moufarrej explained, it tells you more about whats going on in the process of building a baby and what might go wrong.

The test looks at RNA molecules found in the mothers blood.

Looking at those seven types of RNA molecules, theyre higher in women who deliver preterm than full-term, Moufarrej said.

The team hopes doctors will then be able to start treatments that will delay delivery. Haven spent the first 241 days of his life in the hospital, has had seven surgeries since birth, hes on oxygen and takes 18 syringes of medication daily. But as his mom says, hes a fighter.Smith said to Haven, I get to watch you stand up, smile, and give people hope.

In low-resource settings, a test to predict time to delivery has tremendous potential to impact womens health particularly for disadvantaged women with limited access to hospitals. Because a blood test is cheap and easy to use, it has the potential to complement ultrasound and expand access to good prenatal care. Amanda is documenting little Havens journey. You can follow them both on Facebook at https://m.facebook.com/TeamHavenGreyson/

Contributors to this news report include: Marsha Lewis, Field Producer; Evan Boarders, Videographer; Cyndy McGrath, Supervising Producer; Roque Correa, Editor.

To receive a free weekly e-mail on Medical Breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk

BACKGROUND: When a baby is born more than three weeks earlier than the predicted due date, that baby is called premature. Premature babies (preemies) have not grown and developed as much as they should have before birth. Most of the time, doctors dont know why babies are born early. When they do know, its often because a mother has a health problem during pregnancy, such as diabetes, hypertension, heart or kidney problems, and an infection of the amniotic membranes or vaginal or urinary tracts. Other reasons why a baby may be born early include bleeding, often due to a low-lying placenta or a placenta that separates from the womb, having a womb that isnt shaped normally, carrying more than one baby, being underweight before pregnancy or not gaining enough weight during pregnancy, or mothers who smoke, use drugs, or drink alcohol while pregnant.(Source: https://kidshealth.org/en/parents/preemies.html)

TREATMENT: Predicting a premature baby could help doctors execute treatment options that may delay delivery. Mira Moufarrej, a Bioengineering PhD Student at Stanford University said, They use ultrasound to estimate in the first trimester how long the baby is. And they know that in the first trimester the relationship between the length of the baby now and due date is a linear relationship. Now if you measure the baby in the second trimester or the third trimester, thats not necessarily the case because at that point differences in humans come into play. Moufarrej says there are a few treatments, but they do not work well. You can do progesterone injections during pregnancy. And then if a woman has a short cervix then you can do a cervical circlage. But theres a narrow group of women that fit that scope and who deliver preterm, and they havent been shown to be that effective.(Source: Mira Moufarrej)

NEW TESTS: Moufarrej talked about the blood tests, So we developed two blood tests. The first one predicts gestational age similar to ultrasound, so when a baby will be due, but it does it in the second and the third trimester as opposed to the first. So, for women who live far away from the clinic or women who dont know theyre pregnant until later in life, this serves as a complement and a substitute whereas in the past there was no substitute to ultrasound. The test had so far shown 80 percent accuracy. (Source: Mira Moufarrej)

FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:

Samantha BealDirector, Media and Public Relations650-498-7056SBeal@stanfordchildrens.org

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you knowto seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at mthomas@ivanhoe.com

Continue reading here:
HealthWatch: Predicting Preemies: Building Healthier Babies - WeAreGreenBay.com

It may be difficult to envision, but there is a potential future be it 10, 20 or even 30 years down the line where humans are able to plan a cozy vacation into space, blast by a series of satellites that now provide them with Internet access and have their most serious illnesses treated by allowing bioengineers to alter their DNA.

Its one possible future that proactive investors, even those in typically reactive institutional settings, have begun to place large and risky bets on becoming a reality.

In April, the Ontario Teachers Pension Plan created a new department called the Teachers Innovation Platform that has a mandate to invest in disruptive tech and made its first big splash in June by backing Elon Musks SpaceX. The pension plan has particular interest in the companys Starlink project, one that aims to fire more than 11,000 satellites into low orbit, interlink them all and have them act as a new provider of Internet connectivity.

For investing ... you want to look 15 to 20 years down the line and say: 'Is this still going to be impacting peoples' lives?

The Canada Pension Plan Investment Board has put a similar emphasis on investing in disruptive technology, announcing in late 2018 that it had made a private investment in Zoox, a California-based company that aims to operate a fleet of robo-taxis. Only months ago, the pension plan bought US$162 million worth of Skyworks Solutions Inc., a semiconductor firm creating chips that will allow the next wave of phones to work in 5G networks.

As for retail investors, theyve likely never had as many options to hedge their portfolio toward the future. The 2019 IPO market offered them even more, bringing a basket of futuristic options to the market, including Beyond Meat Inc., a producer of plant-based meat, and Virgin Galactic Holdings Inc., the latest brainchild of Richard Branson, which is developing spacecraft that may allow for the development of a space tourism sector.

But the investors buying these stocks arent buying them with the hope that theyll hit their peak in 2020.

You have to recognize the world is changing, said Hans Albrecht, the portfolio manager for Horizons ETFs Industry 4.0 fund. Theres nothing wrong in investing in Pokemon cards if theyre hot now or whatever the latest trend may be, but thats a trade. For investing you want to look 15 to 20 years down the line and say: Is this still going to be impacting peoples lives?

It wont be long, Albrecht suspects, before his coffee maker is able to receive signals from his mug that tell it to begin brewing a new serving once hes three-quarters of the way through his first cup in the morning.

If that scenario sounds too futuristic, its one that only scratches the surface, he said. When hes running low on espresso packages, a chip in his pantry keeping track of stock may be able to automatically order more from Amazon, which at that point, may have implemented one-hour shipping, to ensure hell never run out.

Thousands of consumers already have access to smart home technology through Google Home or Amazon.com Inc.s Alexa, which allow for the linking of devices such as thermostats, lights and televisions. Its advancements in artificial intelligence and edge computing, which will effectively replace the cloud and allow for individual items in a home to process data, that will bring this technology into the future.

Figuring out how to play technology like edge computing which may very well become mainstream in a decade isnt exactly simple.

Investors will have two options: they can bet on the end point user of the technology in Albrechts coffee scenario, that would mean investing in the company that produces the coffee maker or they can look to the firms that are developing the components that power it.

Albrecht leans towards the latter, suggesting that there would be far too much competition among the end point companies while there would only be a handful of leaders on the components side. A company like Analog Devices Inc., may play a central role in the implementation of that technology because its building everything from the sensors and their networks to processors.

Investors may be able to apply similar logic with 5G, according to CIBC World Markets tech strategist Todd Coupland.

Consumers will likely only begin to see the wide rollout of 5G, which would enable devices to operate at speeds that as much as 100 times faster than the current 4G tech, in 2020. That means that it might be a bit early to invest in device producers such as Apple Inc. or Samsung Electronics Co Ltd. for that exposure. Instead, Coupland suggested investors eye a company like Keysight Technologies Inc., which builds the equipment that carriers have been using to test out their services ahead of launch.

Goldman Sachs expects 50 million to 120 million 5G devices to be active in 2020 and if that should be the case, components manufacturers in Qualcomm Inc. and Marvell Technology Group Ltd. may warrant attention as would providers such as Nokia Ovj, which already has 50 deals in place to install its radio access equipment, AirScale, around the world. The equipment supports multiple frequencies and allows for a quick transition over to 5G.

That list doesnt include the Canadian telcos and for good reason.

In Canada, Rogers and Bell, their attitude is: See how it goes in the U.S. and well be at least one year behind, Coupland said.

5Gs full potential likely wont be reached for a decade, he said, and the futuristic possibilities it opens up will likely only be reached in the second half. When combined with the power of quantum computing, managing a fleet of self-driving cars and, who knows, removing traffic lights from the streets becomes a possibility, according to Christian Weedbrook, the CEO of Toronto-based quantum computing company Xanadu.

Weedbrooks company has gained the attention of Georgian Partners, a private-sector venture capital firm that has invested hundreds of millions of dollars in upstart Canadian tech companies.

What makes quantum computing, a draw for Jason Brenier, Georgians vice-president of strategy, is its ability to solve previously unsolvable problems.

Weedbrook imagines a future where quantum computers control hundreds of autonomous vehicles for Uber Inc. or Lyft Inc. and provide each individual car with the fastest route to its destination, analyzing traffic, time a trip perfectly so that red lights can be mostly or completely avoided, and in the case of a pool scenario, figure out how to do that with multiple stops.

Investing in early stage technology comes with its challenges. Because Georgian focuses on private investments, there is no stock performance to point to and not much in the way of fundamentals to rely on.

Many of these tech companies that are seeking funding from the firm may show promise but wont pan out in the future. Brenier knows this and says thats one of the reasons why Georgian has its own scientists on staff.

Instead of making blind bets on the future, Georgian turns to its applied research and development team to identify new opportunities based on new academic research and to even conduct their own in order to determine whether a new idea is actually viable.

That gives us some unique insight into how some of these things are taking off, how practical they are from an investment perspective and determining the timing of some of them, Brenier said.

The Georgian team is futurist, but theres still a limit on how far in advance they want to support a new wave of tech. We dont want to work on things that take 20 years to make a breakthrough, Brenier said.

Where breakthroughs may be even more rare for futurist investors, but the potential returns all the sweeter is in health care. The possibilities here, especially when tech plays a part of the equation, appear to be boundless.

Albrecht sees the potential in robots being able to perform surgery on humans. The portfolio manager highlighted Intuitive Surgical Inc. and its da Vinci Surgical System as an example of how this is already occurring. Through a console that offers them a 3D view of the surface area theyll be operating on, surgeons can use controllers to perform procedure with four robotic arms that offer a greater range of motion than human limbs.

Intuitive doesnt just sell the machines, it sells the accessories such as scalpels that are replaceable and need to be repeatedly ordered. So the more da Vinci units it sells, the more it opens itself up for further gains to its bottom line through accessory sales.

The next step, Albrecht said, is for this technology to allow surgeons to perform surgeries around the world remotely. After thats accomplished, humans may be removed from the equation altogether with AI.

You take the smartest doctors in the world and they might just have the slightest tremor in their hand and might not get it perfect, but a machine will come as close to that as possible, he said.

Health care now makes up about a quarter of the CIBC Global Technology Fund, which is co-managed by Michal Marszal, who has a particular interest in gene therapy.

The technology may still be in development, but Marszal said scientists will soon be able to treat certain conditions, specifically those that plague humans as a result of mutated genes, by biologically engineering new sequences to replace them.

Take haemophilia, a condition that reduces the ability of a persons blood to clot. Treating haemophilia A, which is caused due to a deficiency of a protein called factor VII, may soon be possible by removing cells from the patient, biologically engineering gene sequences with the protein in them and reinserting them.

Gilead Sciences Inc., a company that is in Marszals mutual fund, is working on gene therapy that might even be able to fight cancer. According to Marszal, the process involves removing immune cells from a human body and genetically modifying them so that they become supercharged and are better positioned to fight cancer.

The returns on investment in successful therapies are extremely high, Marszal said. Thats really the next decade or 25 years in medicine.

Thinking that far ahead may be difficult for the average investor, who is often concerned with year-end returns. But it might be worth stopping as some futurists do, even during a quiet moment like a morning coffee, to consider just how different the world will look in a decade and perhaps selfishly, how theres profit to be made from it.

Email: vferreira@nationalpost.com | Twitter:

Continue reading here:
From space tourism to robo-surgeries: Investors are betting on the future like there's no tomorrow - Financial Post

Technicians detect a non-alcohol drink made of bamboo in a biotechnology company in Anji County, east Chinas Zhejiang Province, June 3, 2016. Anji is known for its pleasant environment with flourishing bamboo plantations and many scenes from the famous movie Crouching Tiger, Hidden Dragon were shot here. The county persists in green, low-carbon development, and strives to protect environment as well as to develop local economy. China has pledged to coordinate its efforts of environmental protection and economic development in 2019, an important year for winning the tough battle against pollution. At the annual Central earlier this month, authorities called for building on this years achievement in pollution control, making more efforts and input in 2019. Since the turn of this year, China has made solid efforts to combat pollution and seen constant improvement of the environment. The Central Economic Work Conference made it clear that local governments must avoid past simple and unscrupulous practices in dealing with environmental problems. (Xinhua/Tan Jin)

The in North Chinas Hebei Province plans to build a genetic data center, in an attempt to develop the areas bioscience and biotechnology industries, the Hebei provincial government said.

In a document released by the provincial government on Monday to support the provinces bioengineering and pharmaceutical industry, companies are encouraged to undertake technical research into gene therapy.

In addition, the province supports the clinical application of gene sequencing technology, and the establishment of a genetic testing application demonstration center and public technology platform.

The province will allocate more money to support the study of bioscience, bioengineering and biomedical engineering in local universities as a way to cultivate talent, said the document.

Hebei is looking to the future because the gene-related industry is really new in China, Wang Jun, deputy director of the department of information at the China Center for International Economic Exchanges, told the Global Times on Wednesday.

As a millennium plan of our country, Xiongan must foster its own competitive industries The move by Hebei is a way to look ahead, to explore and develop a promising industry at an advanced technological level.

Wang noted that based on current conditions, the main focus in Xiongan is developing light industry as well as high-technology sector.

Being adjacent to Beijing and North Chinas Tianjin Municipality, both of which have abundant technology resources, Xiongan New Area can take advantage of the scientific research institutions, companies and talent in the two cities, he said.

If Xiongan can aggregate the resources in the genetic area and grab a market share at an early stage under the guidance of policy, it will have a great opportunity to develop the gene-related industry well, Wang said.RELATED ARTICLES:

Go here to read the rest:
Xiongan plans genetic therapy and data center, will explore bioscience and biotech - Dodson Digest

A computerized strike zone could be on the way to Major League Baseball. The umpires union struck a deal with MLB officials last weekend to cooperate and assist with the implementation of a digitally governed strike zone as part of a larger contract, according to a person with knowledge of the deal.

Players, coaches and fans have clamored for such a reform after a heartily scrutinized postseason of officiating that saw baseball fans and observers calling their own balls and strikes, often at odds with umpires decisions.

With game telecasts now routinely including a strike zone projected on the screen, fans can decide for themselves after each pitch whether an umpire was correct, with controversial rulings casting a shadow over a game thats already grappling with other structural issues, including pace of play and rising strikeout and home run numbers.

The five-year agreement between umpires and MLB, part of a new labor deal first reported by The Associated Press, provides umpires significant increases in compensation and retirement benefits designed to let older umpires retire sooner. In exchange, the umpires will advise Commissioner Rob Manfred on the development and implementation of ABS, the leagues proprietary automated balls and strikes system developed by sports data firm TrackMan.

The independent Atlantic League, an eight-team minor league unaffiliated with MLB franchises, piloted ABS in 2019, judging the experiment a great success. MLB deployed the system in the Arizona Fall League in September and October, and will test it again this spring and summer in the Class A advanced Florida State League.

A source with knowledge of the systems rollout said Manfred is eyeing activating the digital strike zone in the big leagues in as soon as three seasons.

The agreement with umpires, if all goes according to plan, will help push baseballs officiating into the 21st century. Where every other aspect of baseball has been quantified down to a science there are bioengineering labs designed specifically to calibrate pitchers form and batters swings the strike zone, the games very foundation, has always been subject to human biases.

Umpiring a professional baseball game is staggeringly difficult, and major- and minor-league umpires are the best in the world at their jobs. But they still get a great number of ball and strike calls wrong. A 2019 study from Boston University that examined 11 years worth of MLB ball/strike calls found umpires get approximately one in every five calls wrong. (That sounds like a lot, and it is, but remember that umpires dont make a call on every pitch. There are foul balls, balls put in play, check swings, and so on, leaving far fewer ball/strike calls than total pitches.)

Umpires have especial blind spots in some areas of the strike zone, the study found. They miss calls at the bottom left and bottom right portions of the strike zone, the most important parts of the zone, 14.3 percent and 18.3 percent of the time, respectively.

Simply put, ABS and get used to saying that wont miss those calls. But it will reconfigure the modern conception of the strike zone. For one, its zone is larger than the one imagined by most players and fans. The K zone projected on television is one dimensional. It looks like a narrow window through which a pitcher must fit the ball. But the real strike zone is three dimensional. All a pitch must do is skim a piece of that zone to be called a strike. ABS doesnt have blind spots.

That means the high fastball or looping curveball most umpires considered out of the zone may very well be strikes, according to ABS. Advantage, pitcher.

However, the fastball that tries to paint the inside corner of the plate, or the slider that tries to sweep outside and misses by half an inch wont be strikes in an ABS zone no matter how well a catcher presents the offering. Advantage, hitter.

Beyond the technological improvements, paying umpires more and allowing them to retire earlier should improve the standard of the officiating workforce. The BU study found the best umpires on balls and strikes are younger and average fewer years of big league experience. Of the top 10 umpires between 2008 and 2018, all of them were younger than 40. The most experienced had only been in the major leagues for five years. The worst umpires were all 50 or older and had spent an average of 20.6 years in the majors.

MLBs umpiring corps must get younger. The average age of a major league umpire is 46, around the age when performance behind the plate starts peaking. The umpiring corps is entirely male and almost entirely white, too. Increased compensation could be a strong motivator for more diverse candidates to pursue the profession, though MLB and the umpires union also need to increase their diversity outreach. Professional baseball is one of the most racially and ethnically diverse sports in the world. Its officials dont reflect that diversity.

Opponents of the digital strike zone need not worry too much: This is not the end of umpiring as we know it. ABS still requires a home-plate umpire to administer the game. The software is not nearly advanced enough to make complex safe or out calls on the bases. MLB wont be cutting any umpiring jobs.

When the ABS system is implemented, home-plate umpires wear an earpiece connected to an iPhone in their pocket. That connects via WiFi to TrackMan radar systems installed in the ballpark. The software announces Ball or Strike to the umpire, who announces the call to the players and crowd. It feels and looks like a normal baseball game.

But this would be arguably technologys largest integration into the officiating of major American sports, which have lagged behind the rest of the world in that category. European soccer employs goal line technology to determine indisputably whether a shot has scored. Tennis has the Hawk-Eye instant-replay system which tracks whether balls are in or out. Cricket uses Hawk-Eye for a complex and controversial call, leg before wicket, which is considerably more advanced than a digital strike zone.

ABSs successful rollout could lead American sports fans and executives to consider the merit of even more officiating technology. Perhaps technology could help determine if a batted ball was fair or foul, a home run or in play? In basketball, whether a ball was out of bounds? In football, whether a runner achieved a first down or a touchdown?

For Major League Baseball, ABS is a far less intrusive technology than opponents of robo umps once feared. But it would reshape the game and its officiating.

Go here to read the rest:
'Robo umps' will help bring baseball into the 21st century - The Keene Sentinel

NEW YORK, Dec. 26, 2019 The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025.The global omega-3 market size is estimated to be valued at USD 4.1 billion in 2019 and is projected to reach USD 8.5 billion by 2025, recording a CAGR of 13.1%. Consumer awareness regarding the health benefits of omega-3 and an increase in application profiling and existing applications finding new markets are some of the significant factors that have led to surge in demand for omega-3 supplements. These factors are projected to drive the growth of the global omega-3 market.

Read the full report: https://www.reportlinker.com/p03670113/?utm_source=PRN

The dietary supplement segment is projected to be the largest segment in the omega-3 market, by application, during the forecast period.Omega-3 increasingly finds application in dietary supplements, functional foods & beverages, pharmaceuticals, infant formula, and pet food and feed. Dietary supplements are estimated to account for the largest market due to the fast-paced and busy lifestyles; consumers prefer consuming dietary supplements to make sure that they get their optimal share of nutrients, and omega-3 supplements are used to improve the health and performance, wherein athletes are advised adequate intake of omega-3 fatty acids for fit and healthy body.

The docosahexaenoic acid (DHA) segment to witness the fastest and largest growth in the omega-3 market, by type, during the forecast period.By type, the market is segmented into docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA).Docosahexaenoic acid (DHA) is the most important omega-3 fatty acid and plays a key role in the development of brain and retina in infants.

The intake of docosahexaenoic acid (DHA) helps in the prevention of cardiovascular diseases and lowering triglyceride levels.

North America is estimated to account for the largest market share in 2019.The North American omega-3 market is estimated to account for the largest share in the global market in 2019.The demand for omega-3 based products has been increasing in the region-specific in the brain and heart health applications.

The omega-3 market in North America is primarily dominated by the US, as the adults prefer to consume fish oil sourced omega-3 capsules as dietary supplements. Also, the omega-3 deficiency among the citizens in the US and Canada has highly impacted the surge in demand for omega-3-based products.

Break-up of Primaries By Value Chain: Demand-side - 45% and Supply-side- 55% By Designation: C level - 33%, D level - 41%, and Others - 26% By Region: Europe - 29%, North America - 27%, Asia Pacific - 22%, South America - 13%, RoW - 9%

Leading players profiled in this report Cargill (US) BASF (Germany) DSM (Netherlands) Croda International (UK) Epax (Norway) Lonza (Switzerland) Orkla Health (Norway) Corbion (Netherlands) KD Pharma (Germany) GC Rieber (Norway) Guangdong Runke Bioengineering (China) Nordic Naturals (US) Golden Omega (Chile) Biosearch Life (Spain) Pharma Marine (Norway) Polaris (France) Sinomega Biotech Engineering (China) Huatai Biopharm (China) Kinomega Biopharm (China) Algisys (US)

Research CoverageThis report segments the omega-3 market into application, type, source, and region. In terms of insights, this research report focuses on various levels of analysescompetitive landscape, end-use analysis, and company profileswhich together comprise and discuss the basic views on the emerging & high-growth segments of the omega-3 market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons to buy this report To get a comprehensive overview of the omega-3 market To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them To gain insights about the major countries/regions, in which the omega-3 industry is flourishing

Read the full report: https://www.reportlinker.com/p03670113/?utm_source=PRN

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/the-omega-3-market-is-projected-to-grow-at-a-cagr-of-13-1-from-2019-to-2025--300979389.html

SOURCE Reportlinker

Read more here:
The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025 - P&T Community